Show simple item record

dc.contributor.authorWall, Laurelie R
dc.contributor.authorWard, Elizabeth C
dc.contributor.authorCartmill, Bena
dc.contributor.authorHill, Anne J
dc.contributor.authorIsenring, Elizabeth
dc.contributor.authorByrnes, Joshua
dc.contributor.authorPorceddu, Sandro V
dc.date.accessioned2020-01-16T03:40:23Z
dc.date.available2020-01-16T03:40:23Z
dc.date.issued2020
dc.identifier.issn1043-3074
dc.identifier.doi10.1002/hed.26060
dc.identifier.urihttp://hdl.handle.net/10072/390518
dc.description.abstractBACKGROUND: Intensive prophylactic swallowing therapy can mitigate dysphagia in patients with oropharyngeal (OP) SCC, however, presents service challenges. This trial investigated the clinical efficacy of three service models delivering prophylactic swallowing therapy during (chemo)radiotherapy ([C]RT). METHODS: Patients (n = 79) with OPSCC receiving (C)RT were were randomized to: (a) clinician-directed face-to-face therapy (n = 26); (b) telepractice therapy via "SwallowIT" (n = 26); or (c) patient self-directed therapy (n = 27). Swallowing, nutritional, and functional status were compared at baseline, 6-weeks, and 3-months post-(C)RT. Patients' perceptions/preferences for service-delivery were collated posttreatment. RESULTS: Service-delivery mode did not affect clinical outcomes, with no significant (P > .05) between-group differences or group-by-time interactions observed for swallowing, nutrition, or functional measures. Therapy adherence declined during (C)RT in all groups. SwallowIT and clinician-directed models were preferred by significantly (P = .002) more patients than patient-directed. CONCLUSIONS: SwallowIT provided clinically equivalent outcomes to traditional service models. SwallowIT and clinician-directed therapy were preferred by patients, likely due to higher levels of therapy support.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWiley Blackwell
dc.publisher.placeUnited States
dc.relation.ispartofjournalHead Neck
dc.subject.fieldofresearchHealth economics
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchDentistry
dc.subject.fieldofresearchcode380108
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode3203
dc.subject.keywordsdysphagia
dc.subject.keywordshead and neck cancer
dc.subject.keywordsprophylactic swallowing therapy
dc.subject.keywordsrandomized controlled trial
dc.subject.keywordsservice-delivery
dc.titleProphylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationWall, LR; Ward, EC; Cartmill, B; Hill, AJ; Isenring, E; Byrnes, J; Porceddu, SV, Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial., Head Neck, 2020
dcterms.dateAccepted2019-12-17
dc.date.updated2020-01-15T23:14:08Z
gro.description.notepublicThis publication has been entered into Griffith Research Online as an Advanced Online Version
gro.hasfulltextNo Full Text
gro.griffith.authorByrnes, Joshua M.
gro.griffith.authorWishart, Laurelie R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record